Resveratrol Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis in Lymphoma Nude Mice by Heme Oxygenase-1 Induction

被引:51
作者
Gu, Jun [1 ]
Song, Zhi-ping [1 ]
Gui, Dong-mei [1 ]
Hu, Wei [1 ]
Chen, Yue-guang [1 ]
Zhang, Da-dong [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Cardiol, Sch Med, Minhang Hosp,Ruijin Hosp Grp, Shanghai 201100, Peoples R China
关键词
Resveratrol; Doxorubicin; Cardiotoxicity; Apoptosis; Heme oxygenase-1; ISCHEMIA-REPERFUSION INJURY; THERAPEUTIC APPLICATIONS; CARDIOTOXICITY; ADULTS;
D O I
10.1007/s12012-012-9178-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Doxorubicin (DOX) has been used in a variety of human malignancies for decades, in particular of lymphoma. But increased cardiomyocyte apoptosis has been implicated in its cardiotoxicity. Resveratrol (RES) generates cardiovascular protective effects by heme oxygenase-1(HO-1)-mediated mechanism. The present study was designed to determine whether RES protected cardiomyocyte against apoptosis through induction of HO-1 in lymphoma nude mouse in vivo. After being developed into lymphoma model, 40 male Balb/c nude mice were randomized to one of the following four treatments (10 mice per group): control, DOX, DOX + RES and DOX + RES + HO-1 inhibitor (zinc protoporphyrin IX, ZnPP). The results showed that DOX injection markedly decreased the body weight, the heart weight and the ratio of heart weight to body weight, but inversely increased cardiomyocyte apoptosis and the level of serum lactate dehydrogenase and creatine kinase. Moreover, DOX injection attenuated HO-1 expression and enzymatic activity as well as increased P53 expression, modulated Bcl-2/Bax expression and enhanced caspase 3 activity. These cardiotoxic effects of DOX were ameliorated by its combination with RES. However, the protective effects of RES were reversed by the addition of ZnPP. Taken together, it is concluded that HO-1 plays a core role for protective action of RES in DOX-induced cardiomyocyte apoptosis in lymphoma nude mice.
引用
收藏
页码:341 / 349
页数:9
相关论文
共 21 条
[1]   LATE CARDIAC TOXICITY OF DOXORUBICIN, EPIRUBICIN, AND MITOXANTRONE THERAPY FOR HODGKINS-DISEASE IN ADULTS [J].
AVILES, A ;
AREVILA, N ;
MAQUEO, JCD ;
GOMEZ, T ;
GARCIA, R ;
NAMBO, MJ .
LEUKEMIA & LYMPHOMA, 1993, 11 (3-4) :275-279
[2]   Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: Role for heme oxygenase-1 down-modulation [J].
Bernuzzi, Francesca ;
Recalcati, Stefania ;
Alberghini, Alessandra ;
Cairo, Gaetano .
CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 177 (01) :12-20
[3]  
Childs AC, 2002, CANCER RES, V62, P4592
[4]   Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma [J].
de Menezes, Daniel E. Lopes ;
Denis-Mize, Kimberly ;
Tang, Yan ;
Ye, Helen ;
Kunich, John C. ;
Garrett, Evelyn N. ;
Peng, Jing ;
Cousens, Lawrence S. ;
Gelb, Arnold B. ;
Heise, Carla ;
Wilson, Susan E. ;
Jallal, Bahija ;
Aukerman, Sharon L. .
JOURNAL OF IMMUNOTHERAPY, 2007, 30 (01) :64-74
[5]   Resveratrol: Preventing properties against vascular alterations and ageing [J].
Delmas, D ;
Jannin, B ;
Latruffe, N .
MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (05) :377-395
[6]   Anthracycline cardiotoxicity: From bench to bedside [J].
Gianni, Luca ;
Herman, Eugene H. ;
Lipshultz, Steven E. ;
Minotti, Giorgio ;
Sarvazyan, Narine ;
Sawyer, Douglas B. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3777-3784
[7]   Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas [J].
Haddy, TB ;
Adde, MA ;
McCalla, J ;
Domanski, MJ ;
Datiles, M ;
Meehan, SC ;
Pikus, A ;
Shad, AT ;
Valdez, I ;
Vivino, LL ;
Magrath, IT .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2070-2079
[8]   Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults [J].
Hequet, O ;
Le, QH ;
Moullet, I ;
Pauli, E ;
Salles, G ;
Espinouse, D ;
Dumontet, C ;
Thieblemont, C ;
Arnaud, P ;
Antal, D ;
Bouafia, F ;
Coiffier, B .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1864-1871
[9]   CO as a cellular signaling molecule [J].
Kim, HP ;
Ryter, SW ;
Choi, AMK .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :411-449
[10]   Inhibition of neointimal formation by trans-resveratrol: Role of phosphatidyl inositol 3-kinase-dependent Nrf2 activation in heme oxygenase-1 induction [J].
Kim, Jung Woo ;
Lim, Sung Chul ;
Lee, Moo Yeol ;
Lee, Jeong Woon ;
Oh, Won Keun ;
Kim, Sang Kyum ;
Kang, Keon Wook .
MOLECULAR NUTRITION & FOOD RESEARCH, 2010, 54 (10) :1497-1505